Company Profile

Company Profile

Home > About CelluPro > Company Profile

Company Profile

1st Chinese cell culture media company supporting the
commercialization of Chinese new drug

 

CelluPro, Ltd., headquartered in Yantai, China, specializes in the development, production (OEM) and sales of serum-free culture media for mammalian cells, and is committed to providing serum-free culture medium products and professional technical services at all stages from early development to commercial production process.

 

Beyond delivering premium-quality cell culture media, we offer comprehensive solutions including custom formulation development and contract manufacturing services. Our products outperform market alternatives in quality and technical support, earning acclaim from biopharmaceutical enterprises across China.

Company Profile
0
First Chinese cell culture media company supporting international BLA submissions
0
Supported the commercialization of 2 new drugs
0
Product titer up to 15g/L
0
Product optimization cased over 50
0
Production capacity as 20,000 liters per batch

R&D Capability

Advanced experimental equipment and top talent team provide strong boost for technological innovation. The R&D team has many years of experience in developing biopharmaceutical process and cell culture media formulation, and master the interaction among media component, cell growth and metabolism characteristics, as well as productivity and quality of target biological drugs. We can provide effective custom media development services. With high-quality team, diversified R&D capabilities and rigorous R&D process, as well as leading development concepts and technical advantages, CelluPro is committed to develop higher quality cell culture media for customers

Development History

2018

Founded and achieved long-term strategic supply partnership with RemeGen

2019

Business expanded overseas

2020

Powder media production line reached to annual output of 1 million liters

2021

Supported commercialization of 2 new drugs
Passed ISO9001 and ISO13485

2022

Declared as technology SME

2023

Declared as high-tech enterprise

Products filed in FDA DMF

Products supplied in USA market

2024

Strategic cooperation with international medium giants

2025

Publish Association Standards